Retrospective Analysis of PET Brain Imaging in Chronic Cancer Pain

Status Completed

Clinical Trial Summary

Cancer pain deteriorated in quality of life and related with numerous psychosocial problems. Over the one third of cancer patient suffered from moderate to severe cancer pain, even under adequate pain management. The 18F-fluoro-2-deoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) images can provide quantitative results in clinical oncology. As a functional neuroimaging, the PET evidently provided anatomical activated regions, size, and spatial extent information. In this retrospective study, we use FDG-PET to investigate changes concerning the glucose metabolism in the brain with or without cancer pain.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Cancer Pain

Clinical Trial Details

NCT number	NCT04537845
Study type	Observational
Source	National Taiwan University Hospital
Contact
Status	Completed
Phase
Start date	March 2, 2020
Completion date	August 8, 2020

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03375515` - PCA vs Non-PCA Intravenous Hydromorphone Titration for Severe Cancer Pain	Phase 3
Recruiting	`NCT03431922` - Endovascular Denervation in Patients With Cancer Pain	N/A
Not yet recruiting	`NCT05265052` - 3D1002 in Combination With Oxycodone Hydrochloride Sustained-release Tablets in Patients With Moderate to Severe Cancer Pain	Phase 2
Withdrawn	`NCT05325164` - Methadone for 'Adenocarcinopathic' Pain Treatment	Phase 3
Completed	`NCT02664987` - Analgesic Treatment for Cancer Pain in South East Asia	N/A
Completed	`NCT01946555` - Prospective Longitudinal Observational Study to Evaluate the Clinical Characteristics and Opioids Treatments in Patients With Breakthrough Cancer Pain	N/A
Active, not recruiting	`NCT04095234` - Integrative Medicine for Pain in Patients With Advanced Cancer Trial (IMPACT)	Phase 2
Recruiting	`NCT05800834` - Benefits of Morphine Gel for Pain Reduction in Patients With Cancer Wounds	Phase 2
Recruiting	`NCT04907643` - Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes	N/A
Completed	`NCT02609828` - Phase 3 Study on the Efficacy and Safety of Tanezumab in Patients With Cancer Pain Due to Bone Metastasis Who Are Taking Background Opioid Therapy	Phase 3
Completed	`NCT03331055` - PENS or TENS for Pain in Pancreatic Cancer	N/A
Recruiting	`NCT05506878` - Auriculo-Nerve Stimulation on Post-Operative Opioid Requirement	N/A
Completed	`NCT00766831` - An Efficacy and Safety Study of Hydromorphone Oral Osmotic System (OROS) in Korean Participants With Cancer Pain	Phase 4
Recruiting	`NCT05051735` - PARASTOP - Paracetamol With Strong Opioids	Phase 3
Not yet recruiting	`NCT05348174` - Randomized Controlled Trial of Virtual Reality Assisted Guided Imagery (VRAGI) for Pain in Advanced Cancer Patients.	N/A
Completed	`NCT05209906` - An Observation Study to Assess the Efficacy and Safety of Proportional Doses of Painkyl® in Patients With Breakthrough Cancer Pain
Completed	`NCT03031938` - Protocol to Monitor the Neurological Development of Infants With Exposure in Utero From Birth to 15 Months in Tanezumab Clinical Studies	Phase 3
Not yet recruiting	`NCT05594459` - Early Treatment With Invasive Technique in Cancer Pain Management	N/A
Withdrawn	`NCT04666623` - Compare the Efficacy and Safety of Intranasal Esketamine in Chronic Opioid Refractory Pain	Phase 2
Not yet recruiting	`NCT05049811` - Effects of Mobile Medicine on Cancer Patients	N/A